查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511941

生物可吸收血管支架市場規模、佔有率、趨勢分析報告：按應用、最終用途、地區和細分市場預測，2024-2030 年

Bioresorbable Vascular Scaffold Market Size, Share & Trends Analysis Report By Application (Peripheral Artery, Coronary Artery), By End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

生物可吸收血管支架市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球生物可吸收血管支架市場規模將達到7.1509億美元，2024年至2030年複合年成長率為8.7%。

由於心血管疾病的盛行率不斷增加以及對有效和微創治療的需求，該市場正在經歷顯著成長。根據 2024 年心臟病和中風統計數據更新情況表，心血管疾病 (CVD) 仍然是美國的重大公共衛生問題，2021 年將有 931,578 人死於心血管疾病。 2021 年，心臟病和中風的影響將是驚人的，奪走的生命比癌症和慢性呼吸道疾病的總合多。

CVD 的盛行率高得驚人，2017 年至 2020 年間，有 1.279 億美國成年人 (48.6%) 患有某種形式的 CVD。 CVD 的經濟負擔也很巨大，2019 年至 2020 年間，直接和間接成本總額總合為 4,223 億美元，其中直接成本為 2,543 億美元，生產力損失和死亡率高達 1,680 億美元。這些統計數據突顯，迫切需要繼續進行研究、預防和治療工作，以解決美國日益成長的心血管疾病負擔。

除了心血管疾病的日益普及之外，生物可吸收血管支架（BVS）的技術進步和強大的產品平臺預計將在預測期內推動市場成長。例如，製造商雅培宣布，2024 年 4 月，美國食品藥物管理局核准依Everolimus洗脫生物可吸收支架（Esprit BTK）用於膝下（BTK）膕窩下疾病患者。這項核准凸顯了 BVS 市場的持續發展和創新，為心血管疾病患者提供了新的治療選擇。

此外，具有增強機械性能的下一代生物可吸收血管支架（BRS）的發展是推動全球市場擴張的關鍵催化劑。先前的BRS面臨支柱厚度和橫斷面高度等挑戰，限制了其廣泛使用。然而，現代 BRS 採用具有卓越機械性能的可吸收材料，可以製造更薄的支柱並減少交叉輪廓，從而改善輸送、兼容性以及與複雜病變和小血管的兼容性。

這些進步改善了臨床結果，例如加速血管癒合、降低血管再阻塞率以及降低支架血栓症等不利事件的風險，從而導致全球範圍內擴大採用 BRS。對微創治療的日益偏好、人口老化以及全球心血管疾病盛行率的上升表明全球範圍內市場的發展前景光明。

生物可吸收血管支架市場報告亮點

  • 2023年，冠脈業務佔收益佔有率為84.59%。這是由於冠狀動脈疾病的高盛行率以及對微創治療的需求不斷增加。此外，生物可吸收支架技術的進步正在改善設備性能和患者治療結果，進一步推動該領域的成長。
  • 2023年，醫院業務收益佔有率最大，超過74.21%。這是由於醫院進行了大量的心血管手術並且擁有先進的醫療設備。例如，根據美國心臟學會的數據，2023 年美國醫院進行了超過 90 萬例冠狀動脈介入治療。如此大量的手術，再加上生物可吸收血管支架的優點，例如減少長期併發症和改善患者預後，有助於在醫院領域佔據最高佔有率。
  • 由於患有心血管疾病的患者數量眾多、醫療基礎設施完善以及先進醫療技術的採用率較高，北美在 2023 年佔據市場佔有率領先地位。此外，該地區是多家市場主要企業的所在地，包括雅培（Abbott）、波士頓科學公司（Boston Scientific Corporation）和美Medtronic） ，他們不斷投資於研發活動，以開發創新產品並擴大其市場佔有率。
  • 市場參與者正在實施各種策略性舉措，以擴大其產品在不同地區的覆蓋範圍和可用性。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章生物可吸收血管支架市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 生物可吸收血管支架市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章生物可吸收血管支架市場：應用估算與趨勢分析

  • 生物可吸收血管支架市場：應用儀表板
  • 生物可吸收血管支架市場：應用變化分析
  • 2018-2030年生物可吸收血管支架市場規模、預測與趨勢分析（依應用）
  • 周邊動脈
  • 冠狀動脈

第5章全球生物可吸收血管支架市場：最終用途估計與趨勢分析

  • 生物可吸收血管支架市場：最終用途儀表板
  • 生物可吸收血管支架市場：最終用途變化分析
  • 2018-2030 年生物可吸收血管支架市場規模、預測與趨勢分析（依最終用途）
  • 醫院
  • 門診護理中心 (ACS)
  • 專科診所

第6章生物可吸收血管支架市場：按國家、產品和最終用途進行的區域估計和趨勢分析

  • 生物可吸收血管支架市場：區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Abbott
    • Kyoto Medical
    • Biotronik
    • Elixir Medical
    • CR Bard, Inc.,
    • Teleflex Incorporated
    • B. Braun Melsungen AG
    • Medtronic Plc
    • Argon Medical Devices, Inc
Product Code: GVR-4-68040-313-5

Bioresorbable Vascular Scaffold Market Growth & Trends:

The global bioresorbable vascular scaffold market size is expected to reach USD 715.09 million by 2030, expanding at a CAGR of 8.7% from 2024 to 2030, based on a new Grand View Research, Inc. report. The market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases and the need for effective, minimally invasive treatments. According to the 2024 Heart Disease and Stroke Statistics Update Fact Sheet, cardiovascular disease (CVD) remains a significant public health concern in the U.S., with 931,578 deaths attributed to it as the underlying cause in 2021. The impact of heart disease and stroke is staggering, as they claimed more lives in 2021 than all forms of cancer and chronic lower respiratory disease combined.

The prevalence of CVD is alarmingly high, with 127.9 million US adults (48.6%) having some form of the disease between 2017 and 2020. The economic burden of CVD is also substantial, with direct and indirect costs totaling USD 422.3 billion between 2019 and 2020, including USD 254.3 billion in direct costs and USD 168.0 billion in lost productivity and mortality. These statistics underscore the urgent need for continued research, prevention, and treatment efforts to address the growing burden of cardiovascular disease in the U.S.

In addition to the increasing prevalence of CVD, technological advancements in the bioresorbable vascular scaffold (BVS) and a robust product pipeline are other factors expected to drive the growth of the market during the forecast period. For instance, in April 2024, the US Food and Drug Administration approved an everolimus-eluting bioresorbable scaffold (Esprit BTK) for patients with below-the-knee (BTK) infrapopliteal disease, according to an announcement from manufacturer Abbott. This approval highlights the ongoing development and innovation in the BVS market, providing new treatment options for patients with cardiovascular conditions.

Moreover, the evolution of next-generation bioresorbable vascular scaffolds (BRSs) with enhanced mechanical properties is a significant catalyst driving the global market's expansion. Previous versions of BRSs encountered challenges such as thicker struts and higher crossing profiles, limiting their widespread application. However, the latest BRSs utilize absorbable materials with superior mechanical attributes, enabling the production of thinner struts and reduced crossing profiles, improving deliverability, conformability, and flexibility for complex lesions and smaller vessels.

These advancements have resulted in improved clinical outcomes, including enhanced vessel healing, reduced restenosis rates, and decreased risks of adverse events like stent thrombosis, fostering increased adoption of BRSs worldwide. The growing preference for minimally invasive procedures, an aging population, and the escalating prevalence of cardiovascular diseases globally indicate a promising trajectory for the market on a global scale.

Bioresorbable Vascular Scaffold Market Report Highlights:

  • The coronary artery segment accounted for a revenue share of 84.59% in 2023. This is due to the high prevalence of coronary artery diseases and the increasing demand for minimally invasive treatments. Additionally, the advancements in bioresorbable scaffold technology have led to improved device performance and patient outcomes, further driving the growth of this segment.
  • The hospitals segment held the largest revenue share of over 74.21% in 2023. This is due to the high volume of cardiovascular procedures performed in hospitals and the availability of advanced medical facilities. Additionally, hospitals often serve as referral centers for complex cases, further driving the demand for bioresorbable vascular scaffolds.For instance, in 2023, hospitals in the U.S. performed over 900,000 coronary interventions, according to the American College of Cardiology. This high procedure volume, coupled with the benefits of bioresorbable vascular scaffolds, such as reduced long-term complications and improved patient outcomes, contributes to the hospital segment's leading market share.
  • In 2023, North America led the market share, due to the presence of a large patient pool suffering from cardiovascular diseases, a well-established healthcare infrastructure, and a high adoption rate of advanced medical technologies. Additionally, the region is home to several key players in the market, such as Abbott, Boston Scientific Corporation, and Medtronic, which are continuously investing in R&D activities to develop innovative products and expand their market presence.
  • Market players are implementing various strategic initiatives to enhance product reach and availability across different geographic regions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application Type
    • 1.2.2. End-use channel
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Segment
    • 2.2.2. End-use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioresorbable Vascular Scaffold Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Bioresorbable Vascular Scaffold Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Bioresorbable Vascular Scaffold Market: Application Estimates & Trend Analysis

  • 4.1. Bioresorbable Vascular Scaffold Market: Application Dashboard
  • 4.2. Bioresorbable Vascular Scaffold Market: Application Movement Analysis
  • 4.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Peripheral Artery
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Coronary Artery
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Global Bioresorbable Vascular Scaffold Market: End-use Estimates & Trend Analysis

  • 5.1. Bioresorbable Vascular Scaffold Market: End-use Dashboard
  • 5.2. Bioresorbable Vascular Scaffold Market: End-use Movement Analysis
  • 5.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Care Centers (ACS)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Specialty Clinics
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Bioresorbable Vascular Scaffold Market: Regional Estimates & Trend Analysis by Country, Product, and End-use

  • 6.1. Bioresorbable Vascular Scaffold Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Application benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Kyoto Medical
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Application benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Biotronik
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Application benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Elixir Medical
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Application benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. C. R. Bard, Inc.,
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Application benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Teleflex Incorporated
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Application benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. B. Braun Melsungen AG
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Application benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Medtronic Plc
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Application benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Argon Medical Devices, Inc
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Application benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America bioresorbable vascular scaffold market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Europe bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
  • Table 20 Germany bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
  • Table 22 France bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
  • Table 24 Italy bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 26 Spain bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 28 Norway bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Sweden bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 30 Sweden bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 32 Denmark bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 37 Japan bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 China bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 39 China bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 India bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 41 India bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 43 Australia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 45 South Korea bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Thailand bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 47 Thailand bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Latin America bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 50 Latin America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Brazil bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 52 Brazil bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 54 Argentina bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 63 UAE bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 65 Kuwait bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Bioresorbable vascular scaffold market segmentation
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Bioresorbable vascular scaffold market application market share analysis, 2023 & 2030
  • Fig. 14 Bioresorbable vascular scaffold market application market: Application Segment dashboard
  • Fig. 15 Peripheral artery market, 2018 - 2030 (USD Million)
  • Fig. 16 Coronary artery market, 2018 - 2030 (USD Million)
  • Fig. 17 Bioresorbable vascular scaffold market by end-use market share analysis, 2023 & 2030
  • Fig. 18 Bioresorbable vascular scaffold market by end-use market: Segment dashboard
  • Fig. 19 Hospitals, 2018 - 2030 (USD Million)
  • Fig. 20 Ambulatory Care Centers, 2018 - 2030 (USD Million)
  • Fig. 21 Speciality Clinics, 2018 - 2030 (USD Million)
  • Fig. 22 Bioresorbable vascular scaffold market by regional market share analysis, 2023 & 2030
  • Fig. 23 Bioresorbable vascular scaffold market: Regional dashboard
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 North America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 30 UK bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 31 France bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 40 China bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 41 India bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 48 MEA bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 53 Company market position analysis